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ABSTRACT The contribution of human gastrointestinal (GI) microbiota and metabo-
lites to host health has recently become much clearer. However, many confounding
factors can inﬂuence the accuracy of gut microbiome and metabolome studies, re-
sulting in inconsistencies in published results. In this study, we systematically investi-
gated the effects of fecal sampling regions and storage and retrieval conditions on
gut microbiome and metabolite proﬁles from three healthy children. Our analysis in-
dicated that compared to homogenized and snap-frozen samples (standard control
[SC]), different sampling regions did not affect microbial community alpha diversity,
while a total of 22 of 176 identiﬁed metabolites varied signiﬁcantly across different
sampling regions. In contrast, storage conditions signiﬁcantly inﬂuenced the micro-
biome and metabolome. Short-term room temperature storage had a minimal effect
on the microbiome and metabolome proﬁles. Sample storage in RNALater showed a
signiﬁcant level of variation in both microbiome and metabolome proﬁles, indepen-
dent of the storage or retrieval conditions. The effect of RNALater on the metabo-
lome was stronger than the effect on the microbiome, and individual variability be-
tween study participants outweighed the effect of RNALater on the microbiome. We
conclude that homogenizing stool samples was critical for metabolomic analysis but
not necessary for microbiome analysis. Short-term room temperature storage had a
minimal effect on the microbiome and metabolome proﬁles and is recommended
for short-term fecal sample storage. In addition, our study indicates that the use of
RNALater as a storage medium of stool samples for microbial and metabolomic anal-
yses is not recommended.
IMPORTANCE The gastrointestinal microbiome and metabolome can provide a new
angle to understand the development of health and disease. Stool samples are most
frequently used for large-scale cohort studies. Standardized procedures for stool
sample handling and storage can be a determining factor for performing micro-
biome or metabolome studies. In this study, we focused on the effects of stool sam-
pling regions and stool sample storage conditions on variations in the gut micro-
biome composition and metabolome proﬁle.
KEYWORDS feces, metabolome, microbiome, sampling regions, storage methods
Over the last decade, with the rapid development of high-throughput sequencingtechnologies and bioinformatic tools, gastrointestinal tract microbiome studies
have made great strides. The human gut microbiome is a complex and immense
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ecosystem of bacterial species. Human gut microbiome research has led to renewed
awareness of the relationship between the microbiome and host disease, including for
example colorectal cancer (1), metabolic syndrome (2), asthma (3), and central nervous
system disorders (4, 5). The most frequent approach to study the gut microbiome
composition is to sequence bacterial DNA extracted from stool samples (6–8). However,
factors that inﬂuence microbial DNA stability can produce signiﬁcant variation in the
gut microbiome composition, affecting conclusions of research ﬁndings. Therefore, the
investigation of different methods for stool sample handling and storage is important
for microbiome studies. Moreover, decreasing oxygen concentrations from the mucosa
to the lumen of the gut can result in an uneven distribution of microbes in stools (9),
leading to increased variation depending on the fecal sample location that was used to
obtain microbial populations. An additional problem using fecal samples as starting
material is that these samples cannot be obtained “on demand” like other types of
samples. For a large cohort, fecal samples may be collected in the privacy of study
participants’ homes and then stored in a domestic freezer before being transported to
the laboratory for analysis (10). Even if these samples were packaged in ice packs or
other protective measures, thawing of the sample may become commonplace on long
trips. Gorzelak et al. found no signiﬁcant change in bacterial taxa when stool samples
were thawed for 7 min and then snap-frozen in liquid nitrogen for no more than four
cycles (11). However, other published studies showed that four or more freeze-thaw
cycles (thawed for 30 min per cycle) can result in a signiﬁcant distortion of microbiota
proﬁles from sputum samples from cystic ﬁbrosis patients (12). Carroll et al. demon-
strated that the microbiota in fecal samples during a 6-month storage period at –80°C
shared more identity with its host of origin than any other sample (13). Vogtmann et
al. found that the bacterial community composition was stable for 96 h at room
temperature in RNALater (14). However, it remains unclear whether RNALater can
preserve the microbiota during freeze-thaw cycles. A better understanding of the
effects of different sampling methodologies and storage conditions on the microbiome
composition is required to reduce variability in microbiome analysis across large sample
cohorts.
Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass
spectrometry (LC-MS) are widely implemented for the detection of metabolites in stool
samples for disease research (15, 16). Metabolome proﬁling is frequently conducted in
conjunction with gut microbiome studies to study the microbiome’s metabolic poten-
tial (17, 18). Therefore, it is worth investigating whether sampling methods or preser-
vation conditions are suitable for combined microbiological and metabolite studies.
Previous studies, however, paid little attention to the association between sampling or
stool specimen storage methods and metabolite proﬁles. In this study, we systemati-
cally investigated the impact of stool sampling regions and stool sample storage
conditions on variations in the gut microbiota composition and metabolic proﬁles in
stool samples from three healthy children.
RESULTS
Sample collection and 16S sequencing. Stool samples were collected from three
healthy 34-month-old study participants from a single community nursery. A summary
of the stool subsample collection is shown in Fig. 1. After dividing each stool sample
into equal parts (parts A and B) along its longitudinal axis, part A was used to identify
an optimal sampling location for microbiome and metabolomic analyses in the absence
of homogenization. Each fecal sample was ﬁrst subdivided into three parts: head, body,
and tail. From each part, we then collected a surface sample, a core sample, and a
combined surface and core sample. Part B was homogenized to evaluate the effects of
different storage and thawing conditions on the gut microbiome community and
metabolome proﬁles and to explore the protective effect of RNALater as a potential
collecting reagent. A standard control (SC) sample, which was frozen in liquid nitrogen,
was included for each fecal sample for comparison. High-throughput sequence analysis
of the bacterial hypervariable V3 region of the 16S rRNA gene was conducted, and
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6,536,310 raw reads from 96 stool samples were obtained. After quality-based trimming
and ﬁltering processes, 5,780,164 qualiﬁed sequences remained. All samples were
rareﬁed to 28,265 reads, which were subsequently clustered into a total of 255
operational taxonomic units (OTUs) (see Table S1 in the supplemental material).
Effects of sampling regions on microbial community. More than 96.33% of
sequence reads of stool samples collected from different sampling locations on the
stool samples from three children mapped to 10 family level taxa (Fig. 2A and Table S1).
Principal-component analysis (PCA) of all 255 OTUs revealed that individual variability
between study participants was the major driver of microbial diversity (Fig. 2B, left
panel; permutational multivariate analysis of variance [PERMANOVA] P  0.001), which
was further conﬁrmed by clustering analysis of 90 OTUs present in at least 80% of the
samples (Fig. 2C). PCA of all 255 OTUs for each study participant individually did not
show signiﬁcant separation based on surface versus core samples (Fig. 2B). Next, we
used three indices to estimate gut microbiota alpha diversity across sampling sites,
including alpha diversity index (abundance-based coverage estimator [ACE]), Shannon,
and Chao1. No signiﬁcant difference in indices was observed across different sampling
locations compared to SC samples (ACE, P  0.104; Shannon, P  0.025, adjusted P
value [Padj]  1.000; Chao1, P  0.459; Fig. 2D, top panel; see also Fig. S1A and B in the
supplemental material). For beta diversity measures, there was no signiﬁcant difference
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in weighted UniFrac beta diversity index (Fig. 2D, bottom panel; P  0.05 by Tukey
honestly signiﬁcant difference test [HSD]). We found no signiﬁcant difference in relative
abundance across different sampling locations compared to SC samples (family level q
test, 0.074  Padj  1.000; phylum level q test, 0.342  Padj  1.000) at the family and
phylum levels. Among the 50 most abundant OTUs accounting for 91.96% of total
reads within sampling groups, the abundance levels of 7 OTUs were signiﬁcantly
different among sampling locations based on multiple comparisons (q test, Padj 0.05;
Table S2). However, no OTUs were signiﬁcantly different in any of the sampling
locations in comparison to SC samples. We conclude that sampling stool samples at
different regions does not have a major impact on the microbial community and their
abundance levels.
Effects of storage and retrieval methods on microbial community. The relative
abundance of the 10 most abundant taxa across different storage and retrieval meth-
ods is shown in Fig. 3A. Similar to the effect of sampling regions, PCA of all 255 OTUs
across different storage and retrieval methods revealed that individual variability
between study participants was the major driver of microbial community composition
(Fig. 3B; PERMANOVA P  0.001), which was further conﬁrmed by clustering analysis of
86 OTUs present in at least 80% (Fig. 3C). The impacts of storage methods on alpha
diversity were not signiﬁcantly different compared to SC samples (ACE, P  0.456;
Shannon, P  0.257; Chao1, P  0.301; Fig. S1C to E). Of the beta diversity measures,
there was no signiﬁcant difference in weighted and unweighted UniFrac distances
between different storage and retrieval methods compared to SC samples (weighted
UniFrac, 0.174  Padj  0.987; unweighted UniFrac, 0.254  Padj  0.991; Tukey HSD;
Fig. S1F and G). Hierarchical clustering analysis based on weighted UniFrac distance
showed that room temperature (RoT) samples were closer to SC samples compared to
other storage and retrieval methods and that subsamples stored in RNALater clustered
together (Fig. S1H).
We observed no difference in relative abundance of samples stored at RoT or
samples that were retrieved with gradual thawing (GT) and fast thawing (FT) compared
with SC samples at the phylum and family levels (family and phylum level q test,
0.105  Padj  1.000). We further analyzed the differences in relative abundance of the
top 50 OTUs (accounting for 88.17% of total reads within the storage method groups)
across RoT, GT, and FT samples. Among the 50 most abundant OTUs, the abundance
levels of 20 OTUs were signiﬁcantly different among different storage and retrieval
methods based on multiple comparisons (q test, Padj 0.05; Table S3). We observed no
difference in the relative abundance of OTUs of RoT samples or samples that were
retrieved with GT compared with SC samples (RoT versus SC, 0.945  Padj  1.000; GT
versus SC, 0.485  Padj  1.000, q test). On the other hand, six OTUs were signiﬁcantly
different in at least one sample stored in RNALater compared to SC samples, suggesting
that RNALater had a more profound effect on the microbiome composition (Table S3).
To study the effect of RNALater on OTU abundance levels in more detail, we grouped
samples that were stored in RNALater and compared the abundance of the 50 most
abundant OTUs to the remaining samples not stored in RNALater for each child
separately. The abundance levels of 18 OTUs were signiﬁcantly lower in samples stored
in RNALater, whereas 16 OTUs were signiﬁcantly more abundant compared to samples
not stored in RNALater (Fig. 3D and Table S4). Of the 18 OTUs that were decreased after
storage in RNALater, 11 belonged to the order Bacteroidales, whereas 11 of the 16 OTUs
whose abundance levels were increased after storage in RNALater belonged to the
order Clostridiales. OTU8 and OTU23 belonged to the Lachnospiraceae family (order
Clostridiales) and were signiﬁcantly increased after storage in RNALater in all three
children (Fig. 3D and Table S4). In conclusion, these results indicate that fecal sample
storage for 48 h at room temperature or in a household freezer followed by gradual
thawing does not signiﬁcantly alter the microbial composition. However, storage in
RNALater signiﬁcantly alters the abundance levels of speciﬁc bacteria especially those
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belonging to the Bacteroidales and Clostridiales orders, although individual variability
outweighed this effect.
Sampling regions and storage and retrieval methods inﬂuenced metabolite
proﬁles. To investigate the inﬂuence of sampling regions and storage methods on
metabolite proﬁles, we performed ultrahigh performance liquid chromatography cou-
pled to tandem mass spectrometry (UPLC–MS/MS) on 96 stool samples. We identiﬁed
a total of 176 metabolites (Table S5). Subsequent analysis showed that the abundance
levels of 22 metabolites varied signiﬁcantly across different sampling locations and that
there were differences between subsample locations and SC samples for only two
metabolites (Table S6). PCA showed that the effect of individual variability was stronger
than the effects of sampling regions on metabolome proﬁles (Fig. 4A; PERMANOVA P
0.001 for individual effects), which was further demonstrated by clustering analysis of
the 50 most abundant metabolites (Fig. 4B). A comparison of surface samples (surface
head [SH], surface body [SB], and surface tail [ST]) versus core samples (core head [CH],
core body [CB], and core tail [CT]) for each study participant individually (Fig. 4A)
showed a signiﬁcant difference for child 2 (P 0.016), whereas no signiﬁcant difference
was observed for child 1 (P  0.534) and child 3 (P  0.272).
When comparing metabolite proﬁles between different storage methods, we per-
formed PCA and found signiﬁcant separation between samples based on individual
variability (Fig. 5A and Table S7; P  0.011 based on PERMANOVA). However, PCA for
each child individually showed that samples with and without RNALater were signiﬁ-
cantly different (P  0.004 based on PERMANOVA; Fig. 5A), which was further demon-
strated by heatmap analysis of the top 50 metabolites (Fig. 5B). The abundance levels
of 26 metabolites varied signiﬁcantly across different storage and retrieval methods
(Table S8). To analyze the effect of RNALater on metabolite proﬁles in more detail, we
FIG 3 Legend (Continued)
RNALater storage (RoT-RL, GT-RL, and FT-RL) versus no RNALater storage (RoT, GT, FT, SC) samples for individual participant PCA. (C) Hierarchical clustering of
86 OTUs present in at least 80% of samples across storage and retrieval methods. (D) OTU read count for OTU2 (top) and OTU23 (bottom) for individual
children’s samples separated by RNALater storage condition. Error bars represent standard errors. Statistical signiﬁcance is indicated as follows: *, Padj  0.05;
**, Padj  0.01; n.s., not signiﬁcant.
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grouped samples that were stored in RNALater and compared the metabolite levels of
all 176 metabolites to the remaining samples not stored in RNALater for each child
separately. We observed a signiﬁcant change in 25% of metabolites. A total of 21
metabolites were signiﬁcantly downregulated and 22 metabolites were signiﬁcantly
upregulated in samples stored in RNALater compared to samples not stored in
RNALater (P  0.05; Fig. 5C and Table S9). Five metabolites were consistently down-
regulated in samples stored in RNALater for all three children (P  0.05): 5-
hydroxylysine, deoxyinosine, glucosamine 6-phosphate, L-lysine, and ribothymidine
(Fig. 5C and Table S9).
DISCUSSION
Although microbial studies have increased rapidly, there is no consensus on quality
control of collection and preservation of fecal specimens. However, different collection
and storage methods may introduce experimental variation, especially for large-scale
studies with many participants. In this study, we found that abundance levels of speciﬁc
microbial families (Bacteroidaceae, Biﬁdobacteriaceae, Rikenellaceae, Ruminococcaceae,
Lachnospiraceae, and Pasteurellaceae) changed signiﬁcantly depending on fecal sam-
pling locations. Since the surface of feces is in closer contact with the intestinal mucosa,
it is possible that the variability is a reﬂection of the various taxa that harbor different
gut microenvironments (19). It is also possible that surface samples are more suscep-
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tible to environmental factors (e.g., oxygen levels) than core samples, since some of the
sampling location variable microbial families (Bacteroidaceae and Biﬁdobacteriaceae) are
obligate anaerobic microorganisms. Gorzelak and colleagues also reported a large
variation in microbes found within fecal samples and on the surfaces of fecal samples
(11), although the speciﬁc microbes were inconsistent with our results. Also, this study
did not further analyze the similarity of the gut microbiome structure between speciﬁc
fecal locations and homogenized fecal samples. Our study showed that the alpha
diversity and overall microbiome structure did not signiﬁcantly differ between subsam-
pling regions and standard control samples (homogenized and snap-frozen sample).
For ﬁeld studies, the goal is to develop convenient and reliable fecal preservation
methods to guarantee gut microbiome study accuracy. Previous studies have reached
inconsistent conclusions about the association between microbiota composition and
room temperature storage conditions. Dominianni et al. found that the microbial
structure and relative abundance of major taxa did not change across different collec-
tion and storage methods, including storage at room temperature for 3 days (20), while
Shaw et al. suggested that storing samples at room temperature introduced signiﬁcant
changes in the microbial community after 2 days (21). Our study found that the
microbiome community was stable when samples were stored at room temperature for
52 h. Gradual or rapid thawing for a longer time (no more than 4 h) introduced slight
changes in the measured microbiome composition. Flores et al. reported that the
bacterial community composition was stable at room temperature if the samples were
stored in RNALater for 7 days (22), and Sinha et al. also found that RNALater can
preserve the microbiome in delayed frozen stool samples (23). However, Choo et al.
found that samples stored in RNALater showed substantial divergence compared to
control samples stored at 80°C (24). Our ﬁndings supported the results of Choo et al.
in that RNALater signiﬁcantly changed the abundance at the OTU level independent of
storage and retrieval methods. Song et al. also suggested that RNALater did not protect
bacteria when stool samples had been frozen and thawed (25), although details
regarding the freeze-thawing were not presented in their study. RNALater can decrease
DNA purity (20) and reduce the extracted DNA yield from feces (11, 26), which may lead
to loss of low-abundance bacteria and a decrease in highly abundant microorganisms.
Similar to other published results (20, 21, 23, 25), we also found that interindividual
variation is greater than the variation introduced by sampling location and storage
methods.
We found that metabolite abundance levels varied for different stool areas, but this
difference did not substantially affect individual differences in metabolite proﬁles. We
found that the abundance levels of approximately 15% of metabolites were signiﬁ-
cantly affected by storage and retrieval methods. The possible reason is that some
metabolites are sensitive to temperature ﬂuctuations or affected by changes in micro-
bial metabolism (27). Washburn et al. (27) found that glucocorticoid metabolites
increased when white-tailed deer feces were stored at room temperature for 7 days.
They suggested that increased microbial metabolism may at least partially explain
these results. We found that storage of stool samples in RNALater signiﬁcantly affected
approximately 25% of metabolites and conclude that storage in RNALater was
not suitable for metabolomic studies. We hypothesize that the main component of
RNALater (thiocyanate) was responsible for the extraction of nucleophilic metabolites.
Conclusion. We conclude that stool sample location does minimally inﬂuence the
variability in microbial community abundance levels. We further conclude that homog-
enizing stool samples is important to reduce variability in metabolomic analysis and
could also aid in reducing variability for some microbial families that vary by sampling
location. Finally, we conclude that the use of RNALater as a storage medium of stool
samples for microbial and metabolomic analyses is not recommended. Keeping exper-
imental variation to a minimum is important especially for large-scale human micro-
biome studies across multiple collection sites and processing laboratories. On the basis
of our results, we recommend that room temperature or household freezers might be
Fecal Sample Processing Effects for Microbiome Studies
January/February 2020 Volume 5 Issue 1 e00763-19 msphere.asm.org 9
an easy and temporary storage condition for reliable detection of microbial abundance
levels and metabolites.
MATERIALS AND METHODS
Subjects and ethics. Three healthy children aged 34 months were enrolled (one boy and two girls),
who were enrolled in the same community nursery for at least 6 months prior to sample collection. Three
meals and snacks were provided by the nursery each day. The primary caregiver provided standard
demographic data, including age, sex, health, and physical condition. No child in this study had any
antibiotic usage or illness diagnosed by clinical examination for 3 months prior to stool sample collection.
This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and
all procedures involving human subjects were approved by the Nanjing medical university ethics
committee (FWA00001501). Written informed consent was obtained from each participant’s guardians.
Fecal sample collection. In the child’s home, fresh fecal samples were directly collected in a
prepared sterile enamel tray. Our researchers immediately processed the whole stool for different
purposes with speciﬁc tools (sterile polypropylene bag with sealing strip, sterile polyethylene tweezers,
and sterile polyethylene toothed knives). We assembled a simple test bench in their bathroom, and we
wiped it with 75% ethanol before the sample was processed. The fecal characteristics were normal, and
each child had on average one bowel movement per day.
Subsample preparation. Subsamples were collected from different stool locations. Each stool
sample was divided into equal parts (parts A and B) along its longitudinal axis. Overall, part A was used
to identify an optimal sampling location for microbiome and metabolomic analysis. Part B was used to
evaluate the effects of different storage and thawing conditions on gut microbiome community and
metabolome proﬁle and to explore the protective effect of RNALater as a collecting reagent. First, part
A was equally separated into three sections according to the order of defecation (head, body, and tail),
four duplicated subsamples (two 200-mg subsamples and two 100-mg subsamples) were collected from
each sampling locations, including the following: (i) surface of fecal head (SH), (ii) surface of fecal body
(SB), (iii) surface of fecal tail (ST), (iv) core of fecal head (CH), (v) core of fecal body (CB), (vi) core of fecal
tail (CT), (vii) surface and core of fecal head [(SC)H], (viii) surface and core of fecal body [(SC)B], and
(iv) surface and core of fecal tail [(SC)T]. Each aliquot was rapidly put into 2.0-ml Eppendorf tubes using
a sharp edge sterile spatula and spoon within 30 min and then frozen in liquid nitrogen until it was used
to extract microbiota DNA or metabolites (Fig. 1).
Sample preparation to test storage and retrieval methods. Part B was collected into a sterile
polypropylene bag with sealing strip, and then homogenized to a uniform consistency. After homoge-
nization, four duplicated aliquots (two 200-mg aliquots and two 100-mg aliquots) were collected for each
storage and retrieval regimen. Two duplicates (200 mg each) were used for studying the microbiome
composition, and the other two duplicates (100 mg each) were used to analyze metabolite proﬁles.
Details of the storage methods are described below and summarized in Fig. 1.
1. Flash-frozen in liquid nitrogen for 52 h (48 h plus 4 h) as a standard control (SC).
2. Frozen in a common household freezer (16°C) for 48 h, then removed from freezer, and kept at
room temperature for 4 hours with ice bag, as the model of gradual thawing (GT).
3. Frozen in a common household freezer (16°C) for 48 h, then removed from freezer, and kept at
room temperature for 4 h without ice, as a model of fast thawing (FT).
4. Frozen with preserving ﬂuid (RNALater) in a household freezer (16°C) for 48 h and then kept at
room temperature on ice for 4 h as a model of gradual thawing of sample with RNALater (Life
Technologies, Carlsbad, CA, USA) (GT-RL).
5. Frozen with preserving ﬂuid (RNALater) in a household freezer (16°C) for 48 h and then kept at
room temperature without ice for 4 h as a model of fast thawing with RNALater (FT-RL).
The two sets of samples (GT-RL and FT-RL) were used to study the protective effects of RNALater on
microbiome structure of thawing frozen stool samples.
6. Stored at room temperature for 52 h (48 h plus 4 h) without adding any protection (RoT).
7. Stored at room temperature for 52 h (48 h plus 4 h) in RNALater (RoT-RL).
A total of 192 stool samples were obtained for 16S and metabolomic analysis. DNA or metabolites
were extracted from each subsample at the end of the storage and retrieval method.
DNA extraction. DNA extraction was conducted in a clean bench (Heraguard ECO clean bench;
Thermo Scientiﬁc). Total DNA of feces was extracted using the Qiagen Stool Minikit according to the
manufacturer’s instructions (Qiagen, Germany). The 16S rRNA gene “hypervariable region V3” was
ampliﬁed using barcoded PCR primers (V3-F, CCAGACTCCTACGGGAGGCAG; V3-R, CGTATTACCGCGGCT
GCTG). The PCR mixtures included approximately 5 to 10 ng DNA template, 3 mol of each primer in
20-l volume of TopTaq buffer containing 2 U of TopTaq DNA polymerase (Qiagen, Germany). After
denaturation at 94°C for 20 s, PCR ampliﬁcation was conducted for 30 cycles using the following
parameters: 2 min at 94°C predenaturation, 60°C annealing for 20 s, 72°C extension for 30 s, and held at
72°C for 10 min. The concentration and purity of DNA were evaluated on 1% agarose gels. DNA was
diluted to 1 ng/l using sterile water.
16S rRNA gene sequencing and quality control. PCR products were puriﬁed with GeneJET gel
extraction kit (Thermo Fisher Scientiﬁc, USA). Sequencing libraries were generated using Illumina TruSeq
DNA PCR-Free Library Preparation kit (Illumina, USA) following the manufacturer’s recommendations,
and index codes were added. The library was sequenced on an Illumina HiSeq platform, and the
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paired-end reads were merged using FLASH software (V1.2.7; http://ccb.jhu.edu/software/FLASH). Low-
quality and short sequences were trimmed using QIIME (28) (V1.7.0; http://qiime.org/scripts/split
_libraries_fastq.html). Chimeras were removed using UCHIME software (29) (http://www.drive5.com/
usearch/manual/uchime_algo.html) and Gold database (30) (http://drive5.com/uchime/uchime
_download.html).
Microbiome bioinformatic analysis. Sequence data analysis and visualization were performed
using QIIME software and R (version 3.1.1). Sequences with 97% identity were gathered into the same
operational taxonomic units (OTUs) by Uparse de novo (29, 31) (Uparse v7.0.1001; http://drive5.com/
uparse/). The most abundant sequences were selected as the representative sequence for each OTU.
Venn diagrams were drawn using the online tool venny 2.1.0 (J. C. Oliveros, 2007 to 2015; http://
bioinfogp.cnb.csic.es/tools/venny/index.html) (32). Taxonomy assignments were conﬁrmed by mothur
(33) according to the SILVA ribosomal database (34), and fast multiple sequence alignment was
performed using MUSCLE (35) (version 3.8.31; http://www.drive5.com/muscle/) with default parameters.
Three indices, including alpha diversity index (abundance-based coverage estimator [ACE]), Shannon,
and Chao1 were applied to assess alpha diversity. A UniFrac distance matrix was calculate by QIIME to
assess beta diversity (36). Dissimilarity between samples was estimated by principal-component analysis
(PCA) (based on UniFrac distance matrix) and nonmetric multidimensional scaling (NMDS) analysis (based
on Bray-Curtis dissimilarity values) (37). UPGMA (unweighted pair group method with arithmetic mean)
clustering tree was used to analyze microbial similarity. All analysis of microbiota structure was per-
formed on a uniform data set after rarefaction to 28,265 reads according to the sample with minimum
number of reads.
Metabolite extraction and metabolome proﬁling analysis. Fecal metabolites were extracted by
the method described by Meng Yu et al. (38). Frozen stool samples (100 mg) were thawed at room
temperature. Ice-cold water (500 l) was added to the sample and then homogenized by vortexing for
15 s. The homogenized samples were further disrupted using ultrasonic wave treatment for 5 min
(power, 60%; four to six pulses), and the supernatant was transferred to a new 2-ml tube after
centrifugation at 14,000  g for 15 min. Methanol (100%) (1,200 l) was added to the remaining pellet
and treated as described above. The two supernatants were merged and ﬁltered through an organic
ﬁltering membrane (diameter, 0.22 m). Finally, 10 l internal quantitative standard was mixed with the
ﬁltered solution and then volatilized to dry. The dry residue was reconstituted in 20 l deionized water,
and an aliquot of 10 l was used for metabolite analysis.
The contents of the reconstituted samples (metabolites) were determined by ultrahigh performance
liquid chromatography coupled to tandem mass spectrometry (UPLC–MS/MS) performed with a
Q-exactive mass spectrometer (Waters, USA). Metabolomic analysis was performed according to our
previous study (39). The column used for the chromatographic separation was a Hypersil Gold C18
column (100 mm by 2.1 mm; diameter, 1.9 m; Thermo Scientiﬁc, Germany) at 40°C. The mobile phase
consisted of acetonitrile containing 0.1% formic acid as mobile phase A and 0.1% aqueous formic acid
(vol/vol) as mobile phase B at a ﬂow rate of 0.4 ml/min. The gradient elution program was as follows: 0
to 3 min, 1% mobile phase A; 3 to 10 min, 1% to 99% mobile phase A; 10 to 30 min, maintained at 99%
mobile phase A; and 13 to 15 min, 99% to 1% mobile phase A. The injection volume was 10 l. The mass
spectrometer was operated in the HESI (heated electrospray ionization) mode. The parameters were as
follows: positive ion mode spray voltage, 3.5 kV; negative ion mode spray voltage, 2.5 kV; capillary
temperature 250°C in the two modes; heater temperature, 425°C; sheath gas ﬂow rate, auxiliary gas ﬂow
rate, and sweep gas ﬂow rate were optimized at 50 arbitrary units (AU), 13 AU, and 0 AU, respectively;
lens voltage, 60 V. The full scanning range was from 70 to 1,050 (m/z), and resolution was 70,000. The
metabolite identiﬁcation was based on the parameters of retention time to mass debris, accurate mass
of standards; this process was performed using the TraceFinder 3.1 (Thermo Fisher Scientiﬁc) software
platform. PCA was used for the data analysis in R (version 3.1.1).
Statistical analysis. For variables that exhibited a normal distribution, a two-way analysis of variance
(ANOVA) test was performed before paired Student’s t test for multiple comparisons. For variables with
a skewed distribution, the nonparametric Friedman test was used. For comparisons that reached
statistical signiﬁcance, a q test was employed to correct for multiple comparisons. Permutational
multivariate analysis of variance (PERMANOVA) was used to assess microbiota or metabolite variability
explained by the corresponding variables. The nonparametric Kruskal-Wallis test was used to determine
effects of storage and retrieval methods and RNALater on metabolite proﬁles. All analyses were carried
out using R software and SPSS, and statistical signiﬁcance level was P  0.05.
Data availability. All sequences are available under the NCBI Sequence Read Archive BioProject
identiﬁer (ID) PRJNA579560.
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